Results 121 to 130 of about 7,183 (232)

Impact of tenecteplase in intermediate and high risk pulmonary embolism

, 2016
S. Thrudeep, Thanasekaran Jayakumar, G Rajesh, Rupesh George, K.G. Geofi, S. Gagan, S. Abdulkhada   +6 more
openalex   +2 more sources

Tenecteplase versus standard care in patients with acute basilar artery occlusion: a multi-centre, prospective, randomised, open-label, blinded endpoint, phase 3, controlled trial

Stroke and Vascular Neurology
Background and purpose There is a scarcity of evidence of tenecteplase administered within the 24-hour window of acute ischaemic stroke due to basilar artery occlusion (BAO).
Bruce C V Campbell, Yongjun Wang, Yunyun Xiong, Lee H Schwamm, Mark Parsons, Marc Fisher, Fana Alemseged, Zhixin Cao, Shuangzhe Wu   +8 more
doaj   +1 more source

PCV99 Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy for the treatment of atrial fibrillation in canada [PDF]

, 1926
Mallow, P.J., Hsiao, C.W., Rizzo, J.A.
core   +1 more source

A system-level approach for deciphering the transcriptional response to prion infection [PDF]

, 2017
Motivation: Deciphering the response of a complex biological system to an insulting event, at the gene expression level, requires adopting theoretical models that are more sophisticated than a one-to-one comparison (i.e. t-test). Here, we investigate the
Altafini, Claudio, Legname, Giuseppe, Segrè, Daniel, Zampieri, Mattia   +3 more
core  

Implementation of reperfusion therapy in ST segment elevation myocardial infarction (STEMI). A policy statement from the Belgian Society of Cardiology and its working group of acute cardiology and interventional cardiology [PDF]

, 2010
peer reviewedMyocardial infarction remains a major healthcare problem. Reperfusion therapy has been shown to influence favourably short- and long-term patient survival.
Berkenboom, G., Claeys, M. J., de Meester, A., Desmet, W., Evrard, P., Gevaert, S., Legrand, Victor, Van de Werf, F., Van Langenhove, G., Vandenbranden, F., Vranckx, P., Vrints, C.   +11 more
core  

Tenecteplase in ischemic stroke treatment [PDF]

Vladimír Nosáľ
openalex   +1 more source

Tenecteplase Versus Alteplase in Acute Ischemic Stroke in Chinese Patients: Protocol for the ORIGINAL Study

Stroke: Vascular and Interventional Neurology
Background Tenecteplase, a bioengineered variant of alteplase, is a new alternative thrombolytic agent. The ORIGINAL study aims to evaluate the efficacy and safety of tenecteplase versus standard care in Chinese patients with acute ischemic stroke within
Xia Meng, Shuya Li, Hongguo Dai, Guozhi Lu, Weiwei Wang, Fengyuan Che, Yu Geng, Minghui Sun, Xiyan Li, Yongjun Wang   +9 more
doaj   +1 more source

Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Alteplase (ALT) is the standard medical therapy, and also approved by food and drug administration (FDA) for acute ischemic stroke (AIS) patients who present within 4.5 h of symptom onset.
Salim Harris, Al Rasyid, Mohammad Kurniawan, Rakhmad Hidayat, Taufik Mesiano, David Pangeran, Marcellinus Michael   +6 more
doaj   +1 more source

Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis

, 2017
D. Kathirvel, G. Justin Paul, G. Prathap Kumar, Gopinath S. Palanisamy, G. Gnanavelu, G. Ravishankar, N. Swaminathan, S. Venkatesan   +7 more
openalex   +1 more source

Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke [PDF]

, 2016
Andrew Bivard, Xuya Huang, Patrick McElduff, Christopher Levi, Bruce Campbell, Bharath Kumar Cheripelli, Dheeraj Kalladka, Fiona Moreton, Ian Ford, Christopher F. Bladin, Stephen M. Davis, Geoffrey A. Donnan, Keith W. Muir, Mark Parsons   +13 more
openalex   +1 more source